Gains from no real PAINS: Where ‘Fair Trial Strategy’ stands in the development of multi-target ligands
Author:
Publisher
Elsevier BV
Subject
General Pharmacology, Toxicology and Pharmaceutics
Reference119 articles.
1. Improving the efficacy-safety balance of polypharmacology in multi-target drug discovery;Ravikumar;Expert Opin Drug Met,2018
2. Multi-target-directed ligands (MTDL) as challenging research tools in drug discovery: from design to pharmacological evaluation;Alcaro;Front Chem,2019
3. Network pharmacology: the next paradigm in drug discovery;Hopkins;Nat Chem Biol,2008
4. The role of fragment-based and computational methods in polypharmacology;Bottegoni;Drug Discov Today,2012
5. The ecstasy and agony of assay interference compounds;Aldrich;ACS Chem Neurosci,2017
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In situ chemical reprogramming of astrocytes into neurons: A new hope for the treatment of central neurodegenerative diseases?;European Journal of Pharmacology;2024-11
2. How do in vitro digestion and cell metabolism affect the biological activity and phenolic profile of grape juice and wine;Food Chemistry;2024-08
3. Deep simulated annealing for the discovery of novel dental anesthetics with local anesthesia and anti-inflammatory properties;Acta Pharmaceutica Sinica B;2024-07
4. Boosting the Accuracy and Chemical Space Coverage of the Detection of Small Colloidal Aggregating Molecules Using the BAD Molecule Filter;Journal of Chemical Information and Modeling;2024-06-26
5. Design and Diversity Analysis of Chemical Libraries in Drug Discovery;Combinatorial Chemistry & High Throughput Screening;2024-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3